Buy Or Sell Opportunity • Apr 21
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 166% to CHF39.00. The fair value is estimated to be CHF31.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Mar 30
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 228% to CHF37.85. The fair value is estimated to be CHF30.56, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making. Annuncio • Mar 23
Gurit Holding AG, Annual General Meeting, Apr 16, 2026 Gurit Holding AG, Annual General Meeting, Apr 16, 2026, at 16:30 W. Europe Standard Time. Reported Earnings • Mar 05
Full year 2025 earnings released: CHF12.90 loss per share (vs CHF5.97 loss in FY 2024) Full year 2025 results: CHF12.90 loss per share (further deteriorated from CHF5.97 loss in FY 2024). Revenue: CHF319.6m (down 26% from FY 2024). Net loss: CHF60.3m (loss widened 116% from FY 2024). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 11% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Annuncio • Dec 16
Gurit Holding AG to Report First Half, 2026 Results on Aug 26, 2026 Gurit Holding AG announced that they will report first half, 2026 results on Aug 26, 2026 Reported Earnings • Aug 23
First half 2025 earnings released: CHF14.59 loss per share (vs CHF0.02 loss in 1H 2024) First half 2025 results: CHF14.59 loss per share (further deteriorated from CHF0.02 loss in 1H 2024). Revenue: CHF164.7m (down 23% from 1H 2024). Net loss: CHF68.2m (loss widened CHF68.1m from 1H 2024). Revenue is expected to fall by 3.5% p.a. on average during the next 3 years compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance. Annuncio • Aug 21
Gurit Holding AG to Report Fiscal Year 2025 Final Results on Mar 02, 2026 Gurit Holding AG announced that they will report fiscal year 2025 final results at 7:00 AM, Central European Standard Time on Mar 02, 2026 Annuncio • Apr 17
Gurit Holding AG Elects Dr. Libo Zhang as New Member of the Board of Directors Gurit Holding AG at its AGM held on April 15, 2025, the shareholders elected Dr. Libo Zhang as a new member of the Board of Directors. Annuncio • Apr 01
Gurit Holding AG Announces Chief Executive Officer Changes, Effective July 1, 2025 Gurit Holding AG announced the appointment of Dr. Tobias Lührig, a German national, as its new Chief Executive Officer, effective July 1, 2025. Dr. Javier Perez-Freije, CFO and current acting CEO ad interim, will continue to lead the company until Tobias Lührig officially starts, after which Javier Perez-Freije will return to the sole role as Chief Financial Officer. With over 20 years of leadership experience in family-owned and private equity-backed companies, Tobias Lührig has a proven track record in operational efficiency, strategic realignment, and margin enhancement. His expertise in right-sizing, fostering resilience during transitions, and aligning global operations makes him the ideal leader for Gurit's ongoing realignment. Tobias Lührig holds a Ph.D. in Mechanical Engineering and an Executive MBA from Harvard Business School. Currently serving as CEO of Bischof+Klein International SE, he combines his engineering, financial, and consulting expertise with a commitment to continuous improvement and corporate culture transformation, which will help to position Gurit for future excellence and growth. Annuncio • Mar 24
Gurit Holding AG, Annual General Meeting, Apr 15, 2025 Gurit Holding AG, Annual General Meeting, Apr 15, 2025, at 16:30 W. Europe Standard Time. Reported Earnings • Mar 06
Full year 2024 earnings released: CHF5.97 loss per share (vs CHF1.59 profit in FY 2023) Full year 2024 results: CHF5.97 loss per share (down from CHF1.59 profit in FY 2023). Revenue: CHF431.7m (down 6.1% from FY 2023). Net loss: CHF27.9m (down 475% from profit in FY 2023). Revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 3.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance. New Risk • Dec 27
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Dividend is not well covered by earnings (dividend per share is over 8x earnings per share). Market cap is less than US$100m (CHF71.0m market cap, or US$78.7m). New Risk • Nov 07
New minor risk - Dividend sustainability The dividend is not well covered by earnings. Dividend per share is over 8x earnings per share. Dividend yield: 2.3% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risks Dividend is not well covered by earnings (dividend per share is over 8x earnings per share). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (CHF71.4m market cap, or US$81.4m). New Risk • Nov 04
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CHF81.4m (US$94.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (CHF81.4m market cap, or US$94.2m). New Risk • Oct 09
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CHF29.10, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF53.01 per share. Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CHF35.45, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 82% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF53.03 per share. New Risk • Aug 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (74% net debt to equity). Share price has been volatile over the past 3 months (7.0% average weekly change). Upcoming Dividend • Apr 15
Upcoming dividend of CHF0.35 per share Eligible shareholders must have bought the stock before 22 April 2024. Payment date: 24 April 2024. Trailing yield: 0.6%. Lower than top quartile of British dividend payers (6.1%). Lower than average of industry peers (2.9%). New Risk • Mar 04
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 31
First half 2023 earnings released: EPS: CHF1.54 (vs CHF3.61 in 1H 2022) First half 2023 results: EPS: CHF1.54 (down from CHF3.61 in 1H 2022). Revenue: CHF244.6m (up 4.2% from 1H 2022). Net income: CHF7.19m (down 57% from 1H 2022). Profit margin: 2.9% (down from 7.2% in 1H 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 92 percentage points per year, which is a significant difference in performance. Annuncio • Aug 18
Gurit Holding AG (SWX:GURN) acquired additional 40% stake in Fiberline Building Profiles A/S from Thorning family for €28.15 million. Gurit Holding AG (SWX:GURN) acquired additional 40% stake in Fiberline Building Profiles A/S from Thorning family for €28.15 million on August 15, 2023. The purchase price of €28.15 million includes a cash consideration and a longer term earn-out.Gurit Holding AG (SWX:GURN) completed the acquisition of additional 40% stake in Fiberline Building Profiles A/S from Thorning family on August 15, 2023. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Andreas Evertz was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improved over the past week After last week's 19% share price gain to CHF97.50, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 16x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF110 per share. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CHF70.30, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF116 per share. Buying Opportunity • Sep 05
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 8.3%. The fair value is estimated to be CHF120, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.1% over the last 3 years. Earnings per share has declined by 64%. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 39% in the next 2 years. Reported Earnings • Aug 19
First half 2022 earnings released First half 2022 results: Revenue: CHF234.8m (down 9.2% from 1H 2021). Net income: CHF16.9m (up 41% from 1H 2021). Profit margin: 7.2% (up from 4.6% in 1H 2021). Over the next year, revenue is forecast to grow 17% compared to a 21% decline forecast for the Chemicals industry in the United Kingdom. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Andreas Evertz was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Apr 15
Upcoming dividend of CHF7.00 per share Eligible shareholders must have bought the stock before 22 April 2022. Payment date: 26 April 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of British dividend payers (4.6%). Lower than average of industry peers (2.6%). Valuation Update With 7 Day Price Move • Mar 03
Investor sentiment improved over the past week After last week's 16% share price gain to CHF1,520, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF610 per share. Reported Earnings • Mar 02
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: CHF467.9m (down 19% from FY 2020). Net income: CHF11.4m (down 76% from FY 2020). Profit margin: 2.4% (down from 8.1% in FY 2020). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.6% compared to a 3.9% decline forecast for the industry in the United Kingdom. Board Change • Sep 25
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Director Rudolf Hadorn was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Apr 09
Upcoming dividend of CHF30.00 per share Eligible shareholders must have bought the stock before 16 April 2021. Payment date: 20 April 2021. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (4.2%). Lower than average of industry peers (1.6%). Is New 90 Day High Low • Mar 05
New 90-day low: CHF2,255 The company is down 6.0% from its price of CHF2,395 on 04 December 2020. The British market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF1,069 per share. Reported Earnings • Mar 04
Full year 2020 earnings released: EPS CHF99.28 (vs CHF96.83 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CHF576.7m (up 3.3% from FY 2019). Net income: CHF46.4m (up 2.6% from FY 2019). Profit margin: 8.1% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Analyst Estimate Surprise Post Earnings • Mar 04
Revenue misses expectations Revenue missed analyst estimates by 1.1%. Over the next year, revenue is forecast to grow 2.3% compared to a 12% decline forecast for the Chemicals industry in the United Kingdom. Is New 90 Day High Low • Jan 14
New 90-day high: CHF2,690 The company is up 33% from its price of CHF2,015 on 16 October 2020. The British market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF2,057 per share. Is New 90 Day High Low • Dec 29
New 90-day high: CHF2,500 The company is up 31% from its price of CHF1,910 on 29 September 2020. The British market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF2,024 per share. Annuncio • Dec 12
Gurit Holding AG to Report First Half, 2021 Results on Aug 17, 2021 Gurit Holding AG announced that they will report first half, 2021 results on Aug 17, 2021 Annuncio • Dec 11
Gurit Holding AG to Report Fiscal Year 2020 Results on Mar 02, 2021 Gurit Holding AG announced that they will report fiscal year 2020 results at 7:00 AM, Central European Standard Time on Mar 02, 2021 Valuation Update With 7 Day Price Move • Dec 10
Market pulls back on stock over the past week After last week's 61% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 25x, down from the previous P/E ratio of 64.5x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 6.1%. Valuation Update With 7 Day Price Move • Dec 07
Market pulls back on stock over the past week After last week's 61% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 24.7x, down from the previous P/E ratio of 64x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 6.1%. Valuation Update With 7 Day Price Move • Nov 30
Market pulls back on stock over the past week After last week's 58% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 22.7x, down from the previous P/E ratio of 53.6x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 8.3%. Valuation Update With 7 Day Price Move • Nov 26
Market pulls back on stock over the past week After last week's 57% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 20.9x, down from the previous P/E ratio of 48.7x. This compares to an average P/E of 37x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 9.1%. Valuation Update With 7 Day Price Move • Nov 20
Market pulls back on stock over the past week After last week's 54% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 21.1x, down from the previous P/E ratio of 45.7x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 8.6%. Is New 90 Day High Low • Nov 20
New 90-day low: CHF879 The company is down 48% from its price of CHF1,688 on 20 August 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF767 per share. Valuation Update With 7 Day Price Move • Nov 13
Market pulls back on stock over the past week After last week's 56% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 19.6x, down from the previous P/E ratio of 45x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 7.7%. Valuation Update With 7 Day Price Move • Nov 07
Market pulls back on stock over the past week After last week's 54% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 20.6x, down from the previous P/E ratio of 45.1x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 17%. Is New 90 Day High Low • Oct 30
New 90-day low: CHF879 The company is down 46% from its price of CHF1,616 on 30 July 2020. The British market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF811 per share. Valuation Update With 7 Day Price Move • Oct 30
Market pulls back on stock over the past week After last week's 56% share price decline to CHF879, the stock is trading at a trailing P/E ratio of 19.8x, down from the previous P/E ratio of 45.1x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total return to shareholders over the past three years is a loss of 17%. Is New 90 Day High Low • Oct 01
New 90-day high: CHF2,025 The company is up 45% from its price of CHF1,398 on 03 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF1,867 per share. Annuncio • Aug 17
Gurit Announces the Appointment of Mitja Schulz as Chief Executive Officer Gurit announced the appointment of Mitja Schulz as Chief Executive Officer and Member of the Executive Committee. As communicated on April 23, 2020, Gurit has been in the process of recruiting the successor of current Chief Executive Officer Rudolf Hadorn. On August 17, 2020, it was announced that Mitja Schulz has been appointed to fill the position. Prior to joining Gurit, Mitja Schulz was Senior Vice President and CEO of ZF Wind Power Antwerpen NV, part of ZF Friedrichshafen. Before this, he held a number of senior management positions within ZF Friedrichshafen and Porschewhere he successfully executed major business transformation and growth programs.